Na Yeon Kim
Net worth: 54 258 $ as of 2024-03-30
Profile
Na Yeon Kim served as a Director at Macrogen, Inc. from 2015 to 2017, and as a Director at The Seed Investment Co. Ltd.
from 2015 to 2018.
She also served as a Director at NeuroBo Therapeutics, Inc. Additionally, she is currently serving as an Independent Director at NeuroBo Pharmaceuticals, Inc. from 2019 to 2023.
Ms. Kim received her undergraduate and graduate degrees from Yonsei University, and also holds an MBA.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-07-26 | 13,266 ( 0.27% ) | 54 258 $ | 2024-03-30 |
Former positions of Na Yeon Kim
| Companies | Position | End |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Chairman | 2020-12-31 |
The Seed Investment Co. Ltd.
 The Seed Investment Co. Ltd. Investment ManagersFinance The Seed Investment Co Ltd (The Seed Investment) is a venture capital firm headquartered in Seoul, Korea. The firm is established in 2015 by The Seed Group Co Ltd. | Director/Board Member | 2018-02-28 |
| MACROGEN, INC. | Director/Board Member | 2017-11-30 |
Neurobo Therapeutics, Inc.
 Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Director/Board Member | - |
Training of Na Yeon Kim
| Yonsei University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MACROGEN, INC. | Health Services |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
The Seed Investment Co. Ltd.
The Seed Investment Co. Ltd. Investment ManagersFinance The Seed Investment Co Ltd (The Seed Investment) is a venture capital firm headquartered in Seoul, Korea. The firm is established in 2015 by The Seed Group Co Ltd. | Finance |
Neurobo Therapeutics, Inc.
Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Na Yeon Kim